FDA Approved: MALARONE — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for Malarone to update labeling, including indications for treatment of malaria and prophylaxis against malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)

Snippet

SUPPL AP for MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)